Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study
使用revumenib抑制Menin治疗NPM1突变复发或难治性急性髓系白血病:AUGMENT-101研究
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2025028357
Arellano, Martha L; Thirman, Michael J; DiPersio, John F; Heiblig, Maël; Stein, Eytan M; Schuh, Andre C; Žučenka, Andrius; de Botton, Stephane; Grove, Carolyn S; Mannis, Gabriel N; Papayannidis, Cristina; Perl, Alexander E; Issa, Ghayas C; Aldoss, Ibrahim; Bajel, Ashish; Dickens, David S; Kühn, Michael W M; Mantzaris, Ioannis; Raffoux, Emmanuel; Traer, Elie; Amitai, Irina; Döhner, Hartmut; Greco, Corinna; Kovacsovics, Tibor; McMahon, Christine M; Montesinos, Pau; Pigneux, Arnaud; Shami, Paul J; Stone, Richard M; Wolach, Ofir; Harpel, John G; Chudnovsky, Yakov; Yu, Li; Bagley, Rebecca G; Smith, Angela R; Blachly, James S